10月份广发基金旗下5只基金跌逾10% 1只成立5年亏3成

Group 1 - In October, five funds under GF Fund experienced declines exceeding 10%, including the Hong Kong Innovative Medicine ETF and two classes of the GF CSI Hong Kong Innovative Medicine ETF (QDII) [1][2] - The GF CSI Hong Kong Innovative Medicine ETF (QDII) fell by 11.61% in October, with its top ten holdings including companies like Innovent Biologics and BeiGene [1][2] - The GF Hong Kong Stock Connect Growth Selected Stocks C and A classes dropped by 10.42% and 10.40% respectively, with cumulative returns of -29.52% and -30.99% since their inception in September 2020 [1][2] Group 2 - The top ten holdings of the GF Hong Kong Stock Connect Growth Selected Stocks include Alibaba, Tencent, and Xiaomi, reflecting a focus on major technology and biotech firms [2][3] - Liu Jie has managed the first three funds mentioned, while Li Yaozhu has been managing the GF Hong Kong Stock Connect Growth Selected Stocks since its establishment [1][3] - The cumulative net values for the A and C classes of the GF Hong Kong Stock Connect Growth Selected Stocks are 0.7048 yuan and 0.6901 yuan respectively [1][3]